Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral ketamine-assisted mindfulness group therapy for alcohol use disorder
ACTRN12622000245796Phase 2Not yet recruiting
- Sponsor
- University of Otago
- Start
- Mar 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial in alcohol use disorder (AUD) comparing Ketamine + mindfulness with Midazolam + mindfulness (2 arms). Primary endpoint: Self-reported abstinent drinking days by timeline follow-back. Planned start Mar 2022; status: not yet recruiting.
02
Drugs
ketaminemidazolam
03
Conditions
alcohol use disorder (AUD)
Beyond the preview
Go deeper on ACTRN12622000245796.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12622000245796.